Sophie Testa
University of Insubria
155 Papers
574 Citations
Sophie Testa is an academic researcher from University of Insubria. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 34, co-authored 138 publications. Previous affiliations of Sophie Testa include University of Pavia.
Chat about Author
Papers
Erratum to Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms (Intern Emerg Med, 10.1007/s11739-011-0725-1)
Safety of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study
Riva Nicoletta,Alberto Tosetto,Walter Ageno,Daniela Poli,Sophie Testa,Serena Rupoli,Rita Santoro,Francesco Rodeghiero +7 more
TL;DR: In designated SVT patients, oral anticoagulant treatment was safe, with a reported incidence of major bleeding less than 2% per year and a reasonable case-fatality rate, and it is therefore of utmost importance to accurately select which SVt patients are suitable to be prescribed with VKAs.
1
Documento di consenso FCSA, SIMeL, SIBioC e CISMEL sul monitoraggio di laboratorio dei nuovi farmaci anticoagulanti orali
Giuseppe Lippi,Giancarlo Di Iorio,Sophie Testa,Cesare Manotti,Armando Tripodi +4 more
- 27 Jul 2013
TL;DR: This position paper represents the consensus document of three Italian scientific societies dealing with laboratory issues in thrombosis and haemostasis aimed at reviewing which test should be used to evaluate the anticoagulant effect of each of the NOAs presently available.
1
Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)
Daniela Poli,Walter Ageno,Emilia Antonucci,Salvatore Bradamante,Eugenio Bucherini,Paolo Chiarugi,Antonio Chistolini,Benilde Cosmi,Anna Falanga,A Insana,G. Malcangi,Rossella Marcucci,Giuliana Martini,L Masciocco,Carmelo Paparo,Daniele Pastori,Simona Zerbi and Luciano A. Pedrini,Vittorio Pengo,Pasquale Pignatelli,Andrea Toma,Sophie Testa,Gualtiero Palareti +21 more
TL;DR: In this article , the authors describe the cohort of atrial fibrillation (AF) patients in the START-Register and report outcomes and changes in anticoagulant prescription from 2011 to 2021.
Association of sex with major bleeding risks in sub-Saharian anticoagulated patients with mechanical heart valves: A cohort study from the Khartoum emergency Salam Centre.
Nicoletta Erba,Alberto Tosetto,Suha Abdelwahab Abdallah,Martin Langer,Elena Giovanella,Salvatore Lentini,Franco Masini,A Mocini,Gennarina Portella,Alessandro Salvati,Alessandro Squizzato,Sophie Testa,Gregory Y.H. Lip,Daniela Poli +13 more
TL;DR: Bleeding risk of young MHV patients on oral anticoagulant therapy is higher among women, mainly due to metrorrhagia, and women in the reproductive life are at high risk for gynecological bleeding when treated with anticoAGulants.